Scholl UI, Goh G, Stolting G, de Oliveira RC, Choi M, Overton JD, Fonseca AL, Korah R, Starker LF, Kunstman JW, Prasad ML, Hartung EA, Mauras N, Benson MR, Brady T, Shapiro JR, Loring E, Nelson-Williams C, Libutti SK, Mane S, Hellman P, Westin G, Akerstrom G, Bjorklund P, Carling T, Fahlke C, Hidalgo P, Lifton RP

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Nat Genet 45:1050-4 (2013)
DOI:10.1038/ng.2695

Dutta RK, Soderkvist P, Gimm O

Genetics of primary hyperaldosteronism.

Endocr Relat Cancer 23:R437-54 (2016)
DOI:10.1530/ERC-16-0055

Al-Salameh A, Cohen R, Desailloud R

Overview of the genetic determinants of primary aldosteronism.

Appl Clin Genet 7:67-79 (2014)
DOI:10.2147/TACG.S45620

Chen L, He Y, Wang X, Ge J, Li H

Ventricular voltage-gated ion channels: Detection, characteristics, mechanisms, and drug safety evaluation.

Clin Transl Med 11:e530 (2021)
DOI:10.1002/ctm2.530

Dutta RK, Soderkvist P, Gimm O

Genetics of primary hyperaldosteronism.

Endocr Relat Cancer 23:R437-54 (2016)
DOI:10.1530/ERC-16-0055

Scholl UI, Stolting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP

Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.

Elife 4:e06315 (2015)
DOI:10.7554/eLife.06315

Kessi M, Chen B, Peng J, Yan F, Yang L, Yin F

Calcium channelopathies and intellectual disability: a systematic review.

Orphanet J Rare Dis 16:219 (2021)
DOI:10.1186/s13023-021-01850-0